• Ingredients
  • How It Works
  • FAQ
Sign in

Mutual Nondisclosure Agreement

Version 3.2 · Last updated October 2, 2026 · Supersedes Versions 3.1, 3.0, 2.0 and 1.0

In plain language. Your formulas, your pricing, your customer list and your identity stay yours. This agreement protects three relationships at once: you and us, you and anyone you meet through the Platform, and us and our directory. Protection starts the moment information moves, not later. We have already signed it. Accepting takes one click, costs nothing, and creates no obligation to pay anyone anything.

Version 3.2 · 677f01dd576d

Contents

  1. Who this protects, and against what
  2. Parties
  3. 1. Purpose
  4. 2. The three relationships this Agreement covers
  5. 3. Confidential Information
  6. 4. Exclusions, and how Concept Information is treated
  7. 5. Obligations of every Recipient
  8. 6. Protections specific to this industry
  9. 7. What you are still free to do
  10. 8. When protection starts
  11. 9. Your agreement with your counterparty
  12. 10. What TCM commits to
  13. 11. Compelled disclosure
  14. 12. Term and survival
  15. 13. Return or destruction
  16. 14. No license, no ownership transfer, no warranty, no obligation, no fee
  17. 15. Remedies
  18. 16. Governing law and disputes
  19. 17. Relationship to the other TCM agreements
  20. 18. Notices
  21. 19. Assignment
  22. 20. General
  23. 21. Acceptance and signatures

Who this protects, and against what

If you are a Brand, we protect your brief, concepts, formulas, percentages, claims, launch timing, volumes, packaging, suppliers, budgets and your identity, starting the moment your brief is transmitted to a Manufacturer, before you are named. You can always test your own product for safety, stability and claims.

If you are a Manufacturer, we protect your quotes, pricing, cost structure, minimums, lead times, capacity, base and stock formulas, processes, equipment, quality records and your customer list, starting the moment you receive or send anything through the Platform. A brief you open does not stop you making products in the same category.

Both of you, with each other, get everything above, directly enforceable between you, with no separate NDA to chase, starting the moment a brief reaches a Manufacturer, not at the introduction.

TCM is protected as to the directory, profiles, evidence records, matching logic, scoring and rankings, from acceptance.

Parties

This Mutual Nondisclosure Agreement (this "Agreement") is entered into as of the date you accept it electronically (the "Effective Date") by and between:

XYM Health LLC, an Oregon limited liability company doing business as The Cosmetic Manufacturer, with its mailing address at PO Box 19667, Portland, Oregon 97280-0667, United States, telephone 213-684-7603 ("TCM"); and

the individual or entity accepting this Agreement, as identified in the acceptance record described in Section 21 ("Counterparty", "you").

TCM and Counterparty are each a "Party" and together the "Parties". Each Party may act as a discloser of information ("Discloser") and as a recipient of information ("Recipient"). "Platform" means thecosmeticmanufacturer.com and everything TCM makes available under the Terms and Conditions. "User" means any Brand, Manufacturer, Consultant or other person with a Platform account. Capitalized terms not defined here have the meaning given in the Terms and Conditions.

1. Purpose

The Parties wish to explore and potentially pursue a business relationship in connection with the Platform, including the evaluation of contract manufacturing capabilities, the submission and review of project requirements, the matching of beauty and personal care brands with contract manufacturers, introductions between them, and any resulting commercial discussions (the "Purpose").

In pursuing the Purpose, each Party may disclose information it treats as confidential. This Agreement governs that information.

2. The three relationships this Agreement covers

Confidential information on a matchmaking platform moves in three directions, and all three are covered here.

2.1 You and TCM. Everything you tell us, and everything we tell you, is covered in both directions.

2.2 You and your counterparty. Where your information reaches another User, or another User's information reaches you, these same terms apply directly between the two of you, as set out in Section 9. You do not need to negotiate a separate NDA before a conversation can start, and neither of you is relying on TCM to police it.

2.3 TCM and its own work product. The directory, the structured profiles, the evidence records and the matching logic are our confidential information and you agree to treat them as such, as set out in Section 5.

3. Confidential Information

3.1 General definition. "Confidential Information" means any nonpublic information disclosed by or on behalf of a Discloser to a Recipient, directly or through the Platform, in any form, whether or not marked or identified as confidential, that a reasonable person in the Recipient's position would understand to be confidential given its nature or the circumstances of disclosure. Information disclosed through the Platform is confidential by default. Nothing needs to be stamped, labelled or flagged to be protected.

3.2 Brand Confidential Information. Information disclosed by or about a brand, a prospective brand, or anyone acting for one falls into three groups.

3.2.1 Concept Information. The general description of a project as it appears in a Brief: the product category and format; the general benefit, positioning and claim themes; the target consumer; the target price tier or retail price range; approximate volumes; and general timing windows. Concept Information is protected under the lighter rules in Section 4.3, because Manufacturers receive many Briefs describing similar products.

3.2.2 Brand Technical and Commercial Information. Everything else a brand discloses, including:

(a) formulations, formulas, ingredient lists, INCI listings, percentages, actives, usage levels and technical specifications;

(b) specific claim sets, clinical or consumer testing plans and results, and specific launch dates;

(c) packaging, componentry, decoration, artwork and tooling designs;

(d) ingredient, component and supplier sourcing relationships, and the commercial terms of them;

(e) firm forecasts, order quantities and reorder cadence;

(f) pricing, target landed cost, margins, budgets and funding status; and

(g) retailer, distributor, customer and channel information.

3.2.3 Brand identity. The identity of the brand itself, before a completed introduction, together with anything that would reveal it.

3.3 Manufacturer Confidential Information. Without limiting Section 3.1, information disclosed by or about a contract manufacturer, private label house, filler, packer or similar supplier includes:

(a) quotations, pricing, cost build ups, component and pass through costs, payment terms and rebate structures;

(b) minimum order quantities, batch sizes, lead times, capacity, utilization and scheduling;

(c) equipment, line configurations, processes, parameters, scale up know how and proprietary methods;

(d) formulation know how, stock formulas, base formulas, platform chemistries and formulation libraries;

(e) quality systems, standard operating procedures, audit results, deviation and CAPA records, certificates of analysis and internal documentation;

(f) regulatory files and submissions not on the public record;

(g) customer identities, brand relationships and the existence of them, including any house account list; and

(h) business plans, financial information and ownership matters.

3.4 TCM Confidential Information. Without limiting Section 3.1, information disclosed by TCM includes: the manufacturer directory and any portion of it; profiles, structured datasets, evidence records, source citations and compilations; matching logic, scoring models, question sets, weightings, gates, thresholds and rankings; shortlists and the reasoning behind them; Platform software, interfaces, roadmaps and unreleased features; commercial terms, fee schedules and business plans; and analytics, performance data and outcome data.

3.5 Information disclosed by either Party. The existence, content and status of any brief, request, introduction, acceptance or decline; the identity of any counterparty before a completed introduction; and the terms of this Agreement and of any discussions between the Parties.

3.6 Anonymity is itself confidential. Where the Platform presents a party under an anonymous descriptive label rather than its name, the underlying identity is Confidential Information. No Recipient will attempt to determine, deduce, confirm, triangulate or disclose that identity by any means, including by cross referencing brief details against public filings, trademark or domain registrations, social media, retailer listings, trade show lists, ingredient or component supplier inquiries, or by asking any third party to do so.

3.7 Trade secret tier. The Parties agree that the following are trade secrets and are treated as such under Section 12.3, without time limit: formulations, formulas, percentages and usage levels; base, stock and platform formulas; manufacturing processes, parameters and scale up know how; cost build ups and pricing models; supplier identities and sourcing terms; and TCM's matching logic, scoring models and structured datasets.

4. Exclusions, and how Concept Information is treated

4.1 Exclusions. Confidential Information does not include information that the Recipient can demonstrate:

(a) is or becomes generally available to the public other than through a breach of this Agreement or any other duty of confidence;

(b) was rightfully in the Recipient's possession, without a duty of confidence, before the Discloser disclosed it;

(c) is rightfully received by the Recipient from a third party without a duty of confidence and without restriction on disclosure; or

(d) is independently developed by the Recipient without use of, reference to, or reliance on the Discloser's Confidential Information.

For everything other than Concept Information, that demonstration must be made by contemporaneous written records.

4.2 Combinations. Information does not fall within an exclusion merely because it is embraced by more general information that is public or known, or because individual components of a combination are separately public or known. A formulation is not public because its ingredients are individually known. A cost is not public because the commodity price is published.

4.3 Concept Information. A Manufacturer that makes forty vitamin C serums will receive many Briefs for a forty first. So, for Concept Information only:

(a) the Recipient's obligation is to keep it confidential, and not to use it to replicate the specific product, claim set or launch plan the Brand described, or to take that Brand's concept to another brand;

(b) the Recipient does not need contemporaneous written records to show independent development, and similarity of category, format, benefit, claim theme or price tier is not, by itself, evidence of use;

(c) Section 4.4 does not apply to it; and

(d) brand identity is never Concept Information, and a Brief does not become Concept Information because it is short. Anything in a Brief described in Section 3.2.2 keeps the full protection of this Agreement.

4.4 No residuals right. Some agreements permit a recipient to use information retained in the unaided memory of its personnel. Except as provided in Section 4.3, this Agreement does not. Nothing in this Agreement permits the use or disclosure of Confidential Information on the basis that a person remembered it rather than wrote it down.

5. Obligations of every Recipient

Each Recipient will:

5.1 Use it only for the Purpose. Use the Confidential Information solely for the Purpose and for no other purpose. No Recipient will use Confidential Information to compete with, solicit the customers of, replicate the business of, or gain commercial advantage over the Discloser.

5.2 Protect it. Protect the Confidential Information using at least the degree of care it uses for its own confidential information of similar importance, and in no event less than a reasonable degree of care, including appropriate administrative, technical and physical safeguards.

5.3 Limit who sees it. Disclose the Confidential Information only to its employees, officers, directors, affiliates, professional advisors and contractors who have a genuine need to know it for the Purpose and who are bound by written or professional obligations of confidentiality at least as protective as this Agreement. The Recipient remains fully responsible for any act or omission of those persons as if it were the Recipient's own.

5.4 Not copy it. Not copy or reproduce the Confidential Information except as reasonably necessary for the Purpose.

5.5 Not take it apart. Not reverse engineer, deconstruct, deformulate, analyze or chemically test any sample, formulation, specification, product or software received under this Agreement, except as Section 6.1 permits, and not attempt to derive any source code, matching logic, scoring model or dataset structure from the Platform, except to the extent such a restriction is unenforceable under applicable law.

5.6 Not harvest the Platform. Not scrape, crawl, harvest, index or systematically extract any portion of the Platform or the manufacturer directory, not run briefs, searches or queries for the purpose of enumerating the roster rather than sourcing an actual project, and not use any of it to build, train or improve a competing directory, dataset, matching service or model.

5.7 Tell the Discloser if something goes wrong. Notify the Discloser promptly in writing, and in any event within seventy two (72) hours, on becoming aware of any unauthorized use, disclosure, loss or compromise of Confidential Information, and cooperate reasonably in mitigating it.

6. Protections specific to this industry

Generic NDAs do not address deformulation, quote shopping, brand testing, or the fact that the person who reads a brief is usually a formulator. These are the things that actually happen in personal care, so they are addressed directly.

6.1 Samples, standards and testing.

6.1.1 The general rule. A physical sample, standard, prototype, pilot batch or retail unit provided by one Party to another under this Agreement is provided solely for evaluation of fit for the Purpose. Except as Sections 6.1.2 and 6.1.3 allow, the Recipient will not deformulate it, submit it for analytical deconstruction (including GC MS, HPLC, LC MS, NMR or equivalent), send it to a third party laboratory, or use it for competitive benchmarking or teardown, without the Discloser's prior written consent.

6.1.2 A Brand may always test its own product. "Brand Product" means any sample, prototype, pilot batch or production unit made for a Brand to that Brand's brief or specification. A Brand may, without the Manufacturer's consent, test Brand Product itself or at a qualified laboratory bound to confidentiality, for any of the following: safety, stability, packaging compatibility, microbiological and preservative efficacy testing; SPF, broad spectrum and water resistance testing; dermatological, clinical and consumer perception testing; assay of declared actives and other analyses needed to substantiate claims the Brand intends to make; and anything required for regulatory compliance, including safety substantiation under the Modernization of Cosmetics Regulation Act of 2022 and equivalent regimes. What a Brand may not do without consent is carry out a full compositional deformulation of Brand Product in order to reconstruct a formula that the Manufacturer owns, so that the product can be made elsewhere. Where the Brand owns or has licensed the formula under its agreement with the Manufacturer, this restriction does not apply.

6.1.3 Benchmarks a Brand provides. A benchmark or reference product that a Brand gives a Manufacturer to match, including a retail unit of another company's product, may be evaluated and analyzed by that Manufacturer solely for that Brand's project.

6.1.4 Return, and routine quality work. Unused sample material will be returned or destroyed on request under Section 13. This Section does not restrict routine incoming quality checks, or any testing, agreed in writing between a Brand and its Manufacturer under a separate supply, development or quality agreement.

6.2 Quotations and no quote shopping. A quotation, cost build up, price list, minimum order quantity or lead time provided by a Manufacturer is Confidential Information of that Manufacturer. A Recipient will not show, forward or disclose the quotation, its specific figures or terms, or the identity of the Manufacturer that gave it, to any other manufacturer, supplier or broker, and will not publish, circulate or publicly benchmark it. A Brand may share it with its own employees, advisors and invited Consultants who are bound to confidentiality and who are not themselves manufacturers. A Brand may solicit and compare quotes from as many Manufacturers as it likes, may tell a Manufacturer in general terms that it has received a lower or different offer, and may state its own target price, quantities and timing. It may not show one Manufacturer another Manufacturer's numbers.

6.3 Formulators, chemists and technical staff. Where a Recipient routes Confidential Information to formulation, R&D, application, regulatory or technical personnel, whether employed or contracted, the Recipient is responsible for ensuring each of them is bound by confidentiality obligations at least as protective as this Agreement before they receive it, and for the consequences if they are not. Contract formulators, freelance chemists, toll processors and outsourced labs are expressly included.

6.4 Artificial intelligence and model training. A Recipient will not input, upload or submit another Party's Confidential Information into any artificial intelligence, machine learning or large language model service that uses submitted content to train, tune or improve models accessible to anyone other than the Recipient, or that does not provide a contractual commitment against such use. A Recipient will not use Confidential Information to train, fine tune, evaluate or build any model, dataset or tool that is made available outside the Recipient's own organization. TCM's own commitment on this point is in Sections 10.2 and 10.4.

7. What you are still free to do

A Manufacturer that makes forty lip balms cannot sign something that stops it making lip balms. A Brand should not be locked out of a category. This Section draws the line so nobody has to guess.

7.1 Nothing in this Agreement:

(a) restricts a Party from designing, developing, manufacturing, marketing or selling products or services of its own, including in the same category, format, price tier or ingredient space as anything it learns about here;

(b) restricts a Party from working with, quoting to, or contracting with any other party, including a competitor of the Discloser;

(c) creates any exclusivity, non compete, non solicit of employees, or right of first refusal;

(d) obliges a Party to purchase, quote, accept, respond, or continue any discussion; or

(e) restricts a Party's use of its own preexisting formulations, processes, know how or customer relationships.

7.2 The line. What a Recipient may not do is use the Discloser's specific Confidential Information to do any of it: not the Discloser's formulation, ratios or actives levels; not the Discloser's specific product, claim set, packaging design or launch plan; not the Discloser's disclosed supplier, component or pricing relationships; and not the Discloser's customer or brand identities. Independent development must be genuinely independent. Outside Concept Information, the Recipient bears the burden of showing it under Section 4.1.

7.3 TCM is held to more. Section 7.1 applies to TCM as a Party, but TCM's freedom under it is always subject to its commitments in Section 10, including Sections 10.2 and 10.7.

8. When protection starts

8.1 With TCM. On acceptance of this Agreement.

8.2 Briefs go only to Manufacturers that have accepted. TCM transmits a Brief only to a Manufacturer that has accepted this Agreement. No part of a Brief is included in any invitation, outreach, notification or profile claim flow sent to a Manufacturer that has not accepted it.

8.3 With a counterparty, at the brief. Protection between you and another User attaches at the moment information first moves between you, which on this Platform is when a Brand's Brief is transmitted to a Manufacturer for consideration. It does not wait for the introduction to complete. A Manufacturer that receives a Brief, reviews it, and declines is bound by this Agreement as to everything in that Brief, for the periods in Section 12, whether or not it ever learns the Brand's name.

8.4 Anonymized does not mean unprotected. A Brief presented under an anonymous label carries the full protection of this Agreement. The anonymization protects identity. It does not reduce the confidentiality of the content.

8.5 Declining costs nothing and changes nothing. A Manufacturer may decline any Brief or introduction for any reason or no reason. The Brand is not told who declined. Declining does not release the Manufacturer from this Agreement as to what it already saw.

9. Your agreement with your counterparty

9.1 Direct effect. Where Counterparty and another User exchange Confidential Information through the Platform, whether at the brief stage under Section 8.3 or after a completed introduction, these terms apply directly between Counterparty and that other User, each as Discloser and Recipient, with the same obligations, exclusions, term and remedies set out here, as if they had signed this Agreement directly with each other on the date that information first moved.

9.2 Enforceable by each of you. Each such User is an intended third party beneficiary of this Section and may enforce this Agreement directly against Counterparty, and Counterparty may enforce it directly against that User. Neither of you needs TCM's permission, participation or consent to do so.

9.3 TCM is not in the middle. TCM is not a party to the confidentiality relationship between two Users under this Section, has no liability for it, and has no obligation to enforce it, monitor it, or take sides in a dispute about it. What TCM will do is set out in Section 10.6.

9.4 If you sign your own NDA. If Counterparty and another User sign their own nondisclosure agreement covering the same subject matter, that agreement controls between the two of them to the extent of any conflict, and this Agreement continues to govern each of them and TCM. You are free to do this at any point, and many parties will at the sampling or development stage. This Agreement is there so that nothing has to wait for it.

9.5 If you accepted different versions. Where two Users have accepted different versions of this Agreement, each User's obligations as Recipient are governed by the version that User had most recently accepted when the information first moved to it, and each User may enforce those obligations under Section 9.2.

10. What TCM commits to

Most platform NDAs are a list of things the user must not do. These are the things we are bound to, and you can hold us to them.

10.1 We do not release your identity until you do. A Brand's identity reaches a Manufacturer only when an introduction between them is accepted: when the Manufacturer accepts an introduction the Brand itself requested, or, where the Brand did not request that Manufacturer, when the Brand confirms the Manufacturer's proposal. A Manufacturer's name, address and contact details reach a Brand at the same moment, except that a Manufacturer's name is shown with a proposal it chooses to send. Anonymity before that point is achieved by not transmitting the data, not by hiding it in the interface. Consent is per introduction: an introduction accepted with one Manufacturer does not reveal you to any other Manufacturer on the same brief.

10.2 We do not use your material to compete with you or to train public models. TCM will not use a Brand's brief, formulation, specification, pricing or supplier information, or a Manufacturer's quotes, costs, formulas, house account list or customer information, to develop a competing product, to advantage any other User, or to train, fine tune or evaluate any model made available outside TCM. TCM may create and use aggregated, deidentified and statistical data derived from Platform use, which will not identify you, your counterparty, your brief, your formulas or your commercial terms, and which TCM will not reverse engineer back to an identifiable party or permit anyone else to.

10.3 We do not want your formula. Nothing on the Platform requires you to upload a full formulation. Where you choose to share one with a counterparty, you do so under this Agreement or under your own.

10.4 Our people and our providers are bound. TCM personnel, contractors and advisors are bound by written confidentiality obligations at least as protective as this Agreement and receive Confidential Information on a need to know basis. TCM's service providers, including hosting, database, authentication, email, scheduling, payment, analytics and artificial intelligence model providers, receive only what they need to perform their function and are bound to confidentiality. Any artificial intelligence model provider that processes Confidential Information is contractually bound not to use it to train or improve its models. We do not sell personal data and we do not share it for advertising.

10.5 Security and breach notice. TCM maintains administrative, technical and physical safeguards appropriate to the sensitivity of the information it holds, including encryption of data in transit and at rest, role based access controls, least privilege access, and logging of access to brief and introduction records. If TCM confirms a security incident affecting your Confidential Information, TCM will notify you without undue delay and in any event within seventy two (72) hours of confirming it, with what is known at the time, and will update you as the picture develops.

10.6 The record, and what we will do about a breach. TCM keeps a timestamped record of what was disclosed, to whom, and when: brief transmissions, introduction states, consents, document shares and workspace access. On the written request of a Party to a dispute under this Agreement, TCM will preserve and produce that record to the Parties to it, and will respond to a lawful subpoena or arbitral order for it. Where TCM determines in good faith that a User has breached this Agreement, TCM may suspend or terminate that User's account and remove its profile. This is not a promise to investigate, adjudicate or fund anyone's dispute, and Section 9.3 still applies. It is a commitment that the evidence will exist and will be available to you.

10.7 Brands we own. XYM Health LLC, the company that operates the Platform as The Cosmetic Manufacturer, and its affiliates and principals, own and operate beauty and personal care brands under other names. We would rather tell you than have you find out. Where such a brand uses the Platform:

(a) it is treated as any other Brand: it receives no preferential matching, ranking or placement, no access to another Brand's brief or to any Manufacturer's confidential information beyond what that Manufacturer releases to it through a completed introduction, and no access to scoring internals beyond what any Brand sees;

(b) Confidential Information TCM receives as operator of the Platform is not made available to, and is not used for the benefit of, any brand owned or operated by XYM Health LLC or its affiliates. Operational access to that information is role based, limited to what operating the Platform requires, and logged; and

(c) it is bound by this Agreement on the same terms as any other User.

TCM does not sell placement and does not accept payment to rank.

10.8 What we will not publish. Which Brands work with which Manufacturers is not published. Aggregate and verified product counts may be public. The Brands behind them are not. Outcome and performance data is published only in aggregated form and never attributed to a named Manufacturer or a named Brand.

10.9 We carry cyber insurance. TCM maintains cyber and privacy liability insurance covering security incidents affecting information it holds, and will keep such coverage in force for as long as it operates the Platform. TCM's liability for a security incident, or for its own breach of this Section 10, is governed by Section 14.3 of the Terms and Conditions, which is not subject to the general caps in those Terms.

11. Compelled disclosure

A Recipient may disclose Confidential Information to the extent required by law, regulation, subpoena, court order or governmental authority, provided that, where legally permitted, it gives the Discloser prompt written notice before disclosing, discloses only the portion legally required, and cooperates reasonably, at the Discloser's expense, with the Discloser's efforts to obtain a protective order or other confidential treatment.

12. Term and survival

12.1 Duration. This Agreement takes effect on the Effective Date and remains in effect for as long as you hold a Platform account or continue to use the Platform, and thereafter as set out below. It is not terminable at will while you hold an account. Closing your account, or ceasing to use the Platform, ends future disclosures. It does not release you from anything already disclosed.

12.2 Survival. The obligations in this Agreement survive and continue with respect to each item of Confidential Information for:

(a) two (2) years from the date of disclosure, for Concept Information;

(b) five (5) years from the date of disclosure, for pricing, cost, quotation, customer identity, brand identity and capacity information; and

(c) three (3) years from the date of disclosure, for everything else.

12.3 Trade secrets. With respect to any Confidential Information that constitutes a trade secret under applicable law, including everything listed in Section 3.7, the obligations in this Agreement continue for as long as that information remains a trade secret, without time limit.

12.4 Counterparty obligations survive independently. The obligations owed between two Users under Section 9 survive the termination of either User's relationship with TCM and are not affected by it.

13. Return or destruction

On the Discloser's written request, the Recipient will, within thirty (30) days, return or destroy all Confidential Information of the Discloser in its possession or control, including copies, samples and sample material, and confirm in writing that it has done so.

The Recipient may retain: (a) one archival copy solely for legal and compliance purposes, including records a Manufacturer must keep for batches it has made; and (b) copies held in routine, automated backup or archival systems that are not readily accessible in the ordinary course. Any retained copy remains subject to this Agreement for as long as it is retained.

14. No license, no ownership transfer, no warranty, no obligation, no fee

14.1 No license. No license, assignment, option or other right, express or implied, in or to any patent, copyright, trademark, trade secret, formulation, dataset or other intellectual property is granted by this Agreement or by any disclosure made under it. Confidential Information a Party discloses remains the property of that Party, subject to Section 14.2.

14.2 Who owns what gets developed is not decided here. This Agreement does not decide who owns any formula, specification, process, artwork, tooling or other work developed by a Manufacturer for a Brand, or jointly. That question is governed solely by the development, supply or other written agreement between the Brand and the Manufacturer. Disclosing developed work under this Agreement does not make the disclosing Party its owner, and nothing in Section 14.1 or elsewhere in this Agreement will be read as deciding ownership. A formula or specification a Brand brings to the Platform remains the Brand's. We strongly recommend that Brands and Manufacturers agree ownership in writing before development starts.

14.3 No warranty. ALL CONFIDENTIAL INFORMATION IS PROVIDED "AS IS". No Discloser makes any representation or warranty, express or implied, as to the accuracy, completeness, currency, performance or fitness for any purpose of the Confidential Information it discloses, and no Recipient may rely on it as such. This Section does not limit any representation or warranty a Party gives in a separate signed agreement.

14.4 No obligation to proceed. Nothing in this Agreement obligates either Party to disclose any particular information, to enter into any further agreement, to make or accept any introduction, to place or accept any order, or to continue discussions. Either Party may end discussions at any time for any reason.

14.5 No fee obligation lives in here. This Agreement does not create, limit, waive or alter any fee or commission obligation. There is nothing to pay under this Agreement. Fees are governed solely by the Terms and Conditions and, for Manufacturers, by the Manufacturer Commercial Terms accepted for that account.

15. Remedies

Each Party acknowledges that a breach of this Agreement may cause the other irreparable harm for which monetary damages would be an inadequate remedy. Accordingly, the non breaching Party is entitled to seek injunctive and other equitable relief, without the necessity of posting a bond or proving actual damages, in addition to all other remedies available at law or in equity.

In any proceeding brought to enforce this Agreement, the prevailing Party is entitled to recover its reasonable attorney fees and costs.

Nothing in this Section limits any Party's rights under applicable trade secret law, including the Defend Trade Secrets Act of 2016 and the Oregon Uniform Trade Secrets Act.

Notice under 18 U.S.C. § 1833(b) (applies to individuals subject to United States law). An individual will not be held criminally or civilly liable under any federal or state trade secret law for disclosing a trade secret in confidence to a government official or attorney solely for the purpose of reporting or investigating a suspected violation of law, or in a sealed filing in a lawsuit or other proceeding. An individual suing an employer for retaliation for reporting a suspected violation of law may disclose the trade secret to that individual's attorney and use it in the proceeding, if the filing is made under seal and the individual does not disclose the trade secret except pursuant to court order.

16. Governing law and disputes

16.1 This Agreement is governed by the laws of the State of Oregon, without regard to its conflict of laws rules. The United Nations Convention on Contracts for the International Sale of Goods does not apply.

16.2 Any dispute arising out of or relating to this Agreement will be resolved under the dispute resolution provisions of the TCM Terms and Conditions as in effect on the date the dispute arose, including binding arbitration before a single arbitrator seated in Portland, Oregon under the Commercial Arbitration Rules of the American Arbitration Association or, where any party is established outside the United States, the International Arbitration Rules of the International Centre for Dispute Resolution, and the waiver of class and representative proceedings. A dispute between two Users under Section 9 is resolved on those same terms, between those Users. A later change to those provisions does not apply to a dispute that has already arisen.

16.3 The one year time limit in the Terms and Conditions does not apply to claims under this Agreement. Those claims are subject to the limitations period set by applicable law.

16.4 Notwithstanding the foregoing, either Party may seek temporary or preliminary injunctive relief, or other interim or conservatory measures, to protect Confidential Information in any court of competent jurisdiction, including the courts of the place where a breach occurs or where the Recipient is established. Each Party consents to the non exclusive jurisdiction of the state and federal courts located in Multnomah County, Oregon for that purpose. Seeking such relief does not waive arbitration.

16.5 To the extent permitted by the law governing the proceeding, each Party knowingly and voluntarily waives any right to a jury trial in any proceeding relating to this Agreement.

16.6 International Users. Where a Party is established in a country listed in the TCM International Addendum, that Addendum applies to this Agreement as well as to the Terms and Conditions. Nothing in this Agreement limits any right or obligation that, under the mandatory law of that country, cannot be limited by contract.

17. Relationship to the other TCM agreements

This Agreement is the sole confidentiality agreement between you and TCM in connection with the Platform. It supersedes and replaces Versions 1.0, 2.0, 3.0 and 3.1 of this Agreement as to information disclosed after its acceptance, and replaces any confidentiality terms previously set out in an appendix to the Terms and Conditions.

Where there is a conflict, the order of precedence is:

1. a separate written nondisclosure agreement signed by you and TCM that expressly supersedes this Agreement;

2. the TCM International Addendum, for a Party established in a country it covers, to the extent it modifies this Agreement;

3. a nondisclosure agreement signed between you and another User, as between the two of you only, under Section 9.4;

4. this Agreement, as to confidentiality;

5. the Manufacturer Commercial Terms accepted for an account, as to fees;

6. the Terms and Conditions; and

7. any other Platform documentation.

18. Notices

Notices to TCM: legal@thecosmeticmanufacturer.com, with a copy by mail to XYM Health LLC, PO Box 19667, Portland, Oregon 97280-0667, United States.

Notices to Counterparty: the email address on Counterparty's Platform account, and in the Platform. You are responsible for keeping that address current.

Notice is effective on the next business day after sending, provided no delivery failure is received. A notice terminating discussions, asserting a breach, or commencing a dispute must also be sent by a method producing written confirmation of delivery.

19. Assignment

Neither Party may assign this Agreement without the other's written consent, except to a successor to all or substantially all of its business or assets, whether by merger, acquisition or sale, on written notice, and, where the assigning Party is a User, only to a successor that is not a competitor of TCM. Confidential Information may not be transferred to a successor except subject to this Agreement. Any attempted assignment in violation of this Section is void.

20. General

20.1 Entire agreement. This Agreement, together with the Terms and Conditions, is the entire agreement of the Parties on its subject matter and supersedes all prior understandings, whether written or oral.

20.2 Amendment. This Agreement may be amended only in a writing accepted by both Parties, including by electronic acceptance of a revised version presented in the Platform. Continued use of the Platform is not acceptance of a revised version of this Agreement. A revised version applies only to Confidential Information disclosed after its acceptance.

20.3 Severability. If any provision is held unenforceable, it will be modified to the minimum extent necessary to make it enforceable, or severed, and the remainder stays in full force.

20.4 No waiver. No failure or delay in exercising a right is a waiver of it, and no waiver is effective unless in writing.

20.5 Independent parties. This Agreement creates no agency, partnership, joint venture, franchise or employment relationship, and neither Party may bind the other. TCM is not a broker, agent or fiduciary of any Party.

20.6 Third party beneficiaries. There are none, other than the Users expressly provided for in Section 9.2.

20.7 Counterparts and electronic acceptance. This Agreement may be executed in counterparts, including electronically, each of which is an original and all of which together are one instrument.

20.8 Headings and the summaries. Headings are for convenience and do not affect interpretation. The plain language box at the top of this Agreement, the summary beneath it, and the explanatory notes within it are accurate summaries provided for convenience. Where a summary and a numbered Section differ, the numbered Section controls.

20.9 Construction. This Agreement will not be construed against either Party as drafter. "Including" means "including without limitation".

21. Acceptance and signatures

This Agreement is executed in advance by TCM and is accepted electronically by Counterparty.

Counterparty accepts by entering its full name and title, checking the acceptance box and completing signup, claiming a profile, submitting a brief, or otherwise clicking to accept where this Agreement is presented. That action is an electronic signature under the Electronic Signatures in Global and National Commerce Act (15 U.S.C. § 7001 et seq.) and the Oregon Uniform Electronic Transactions Act, and has the same legal effect as a handwritten signature.

TCM records and retains, as the "acceptance record" referred to in the Parties clause: the accepting person's full name and title, email address, company name, account identifier, the date and time of acceptance, the originating IP address, the version of this Agreement accepted, and a cryptographic hash of the version served. A person accepting for a company represents that they are authorized to bind it. A copy of the accepted version is emailed to Counterparty and remains available for download from Counterparty's account settings at any time, together with every prior version Counterparty accepted.

XYM HEALTH LLC, doing business as The Cosmetic Manufacturer

By: electronic signature

Name: Joseph Schrank

Title: Managing Member

Executed in advance, and effective as to each Counterparty on the date and time of its acceptance.

COUNTERPARTY

Accepted electronically. Name, title, company, email, date and time, IP address, version and version hash as shown in the acceptance record.

Questions about this Agreement: legal@thecosmeticmanufacturer.com

Corrections to a profile: support@thecosmeticmanufacturer.com

Security concerns: support@thecosmeticmanufacturer.com

Terms and ConditionsMutual NDAInternational AddendumManufacturer Commercial TermsService providersWhere we operatePrivacy policy
The Cosmetic Manufacturer

A vetted US network of cosmetic contract manufacturers — matched to beauty brands, grounded in FDA/MoCRA data.

Treating brands the way they should be treated.

Platform

IngredientsHow it worksPricingFAQ

Company

AboutVetting standardsContactPrivacyFor manufacturers — claim your profile

Legal

Terms and ConditionsMutual NDACommercial termsService providersPrivacy

Ingredients by product

After Sun CareConcealersEye PrimersGeneral MoisturizersLeave-in ConditionersMousse & FoamAll ingredients A–Z

Get in touch

support@thecosmeticmanufacturer.comLos Angeles, CA & New York, NY